Lupin Pharmaceuticals Recalls Millions of Eye Drop Bottles Over Contamination Concerns

Lupin Pharmaceuticals has initiated a voluntary recall of over 2.5 million bottles of prednisolone acetate ophthalmic suspension, a widely prescribed corticosteroid eye drop. The recall stems from the potential presence of a foreign substance, which could compromise patient safety. This action aims to mitigate any risks associated with the contaminated product.